From unraveling neuronal network dynamics to developing more physiologically relevant models of neurological diseases, emerging technologies in neuroscience are transforming how researchers investigate brain function, disease mechanisms, and potential therapeutic strategies. As the field continues to evolve, interdisciplinary collaboration is essential to bridge fundamental research and translational applications, accelerate innovation, and address the challenges of neurological disorders.
At MaxWell Biosystems, we are excited to contribute to these advances by empowering researchers with High-Density Microelectrode Array (HD-MEA) technology. By enabling high-resolution recording and analysis of neuronal activity across different in vitro models, including neuronal cultures and brain organoids, our technology provides deeper functional insights into neuronal networks, supporting discoveries in neuroscience, disease modeling, and drug development. We look forward to connecting with the Australasian neuroscience community gathering in Sydney at NeuroAlliance 2026.

Meet us at booth number 18, (level 3). Stop by to meet the MaxWell Biosystems team, exchange ideas, and discover how next-generation HD-MEA technology is advancing our understanding of neuronal function and supporting new approaches to neuroscience research, disease modeling, and drug discovery.